Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 24040051)

1.

Cold atmospheric plasma for selectively ablating metastatic breast cancer cells.

Wang M, Holmes B, Cheng X, Zhu W, Keidar M, Zhang LG.

PLoS One. 2013 Sep 11;8(9):e73741. doi: 10.1371/journal.pone.0073741. eCollection 2013.

2.

Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.

Guerrero-Preston R, Ogawa T, Uemura M, Shumulinsky G, Valle BL, Pirini F, Ravi R, Sidransky D, Keidar M, Trink B.

Int J Mol Med. 2014 Oct;34(4):941-6. doi: 10.3892/ijmm.2014.1849. Epub 2014 Jul 11.

3.

Induction of apoptosis in human myeloid leukemia cells by remote exposure of resistive barrier cold plasma.

Thiyagarajan M, Anderson H, Gonzales XF.

Biotechnol Bioeng. 2014 Mar;111(3):565-74. doi: 10.1002/bit.25114. Epub 2013 Sep 30.

PMID:
24022746
4.

Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells.

Kucerova L, Skolekova S, Matuskova M, Bohac M, Kozovska Z.

BMC Cancer. 2013 Nov 9;13:535. doi: 10.1186/1471-2407-13-535.

5.

Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.

Abalsamo L, Spadaro F, Bozzuto G, Paris L, Cecchetti S, Lugini L, Iorio E, Molinari A, Ramoni C, Podo F.

Breast Cancer Res. 2012 Mar 19;14(2):R50.

6.

Targeting the cancer cell cycle by cold atmospheric plasma.

Volotskova O, Hawley TS, Stepp MA, Keidar M.

Sci Rep. 2012;2:636. doi: 10.1038/srep00636. Epub 2012 Sep 6.

7.

Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.

Sung SY, Liao CH, Wu HP, Hsiao WC, Wu IH, Jinpu, Yu, Lin SH, Hsieh CL.

PLoS One. 2013 Aug 19;8(8):e71637. doi: 10.1371/journal.pone.0071637. eCollection 2013.

8.
9.

Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.

Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Onoyama M, Ohnishi M, Ohara E, Higashi Y, Tanaka S, Yasui W, Chayama K.

Int J Cancer. 2013 Feb 15;132(4):813-23. doi: 10.1002/ijc.27735. Epub 2012 Aug 6.

PMID:
22821812
10.

Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.

Yang M, Kozminski DJ, Wold LA, Modak R, Calhoun JD, Isom LL, Brackenbury WJ.

Breast Cancer Res Treat. 2012 Jul;134(2):603-15. doi: 10.1007/s10549-012-2102-9. Epub 2012 Jun 8.

11.

In vitro effects of RU486 on proliferation and differentiation capabilities of human bone marrow mesenchymal stromal cells.

Yu Y, Wei N, Stanford C, Schmidt T, Hong L.

Steroids. 2012 Jan;77(1-2):132-7. doi: 10.1016/j.steroids.2011.10.017. Epub 2011 Nov 7.

12.

Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo.

Mandel K, Yang Y, Schambach A, Glage S, Otte A, Hass R.

Stem Cells Dev. 2013 Dec 1;22(23):3114-27. doi: 10.1089/scd.2013.0249. Epub 2013 Sep 9.

PMID:
23895436
13.

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G.

Mol Cancer. 2009 Oct 1;8:81. doi: 10.1186/1476-4598-8-81.

14.

Mesenchymal stem cells in early entry of breast cancer into bone marrow.

Corcoran KE, Trzaska KA, Fernandes H, Bryan M, Taborga M, Srinivas V, Packman K, Patel PS, Rameshwar P.

PLoS One. 2008 Jun 25;3(6):e2563. doi: 10.1371/journal.pone.0002563.

16.

Comparison of the behavior of fibroblast and bone marrow-derived mesenchymal stem cell on nitrogen plasma-treated gelatin films.

Prasertsung I, Kanokpanont S, Mongkolnavin R, Wong CS, Panpranot J, Damrongsakkul S.

Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):4475-9. doi: 10.1016/j.msec.2013.05.057. Epub 2013 Jun 6.

PMID:
23910368
17.

Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells.

Wang X, Liu J, Wang Z, Huang Y, Liu W, Zhu X, Cai Y, Fang X, Lin S, Yuan L, Ouyang G.

PLoS One. 2013 Aug 29;8(8):e72962. doi: 10.1371/journal.pone.0072962. eCollection 2013.

18.

CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.

Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, McCarthy JB, Brufsky A, Chivukula M, Khoury T, Hsu DS, Barry WT, Lyerly HK, Clay TM, Ferrone S.

J Natl Cancer Inst. 2010 Oct 6;102(19):1496-512. doi: 10.1093/jnci/djq343. Epub 2010 Sep 17.

19.

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102. doi: 10.1186/1471-2407-9-102.

20.

Mesenchymal stem cells develop tumor tropism but do not accelerate breast cancer tumorigenesis in a somatic mouse breast cancer model.

Usha L, Rao G, Christopherson Ii K, Xu X.

PLoS One. 2013 Sep 12;8(9):e67895. doi: 10.1371/journal.pone.0067895. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk